Loading...
Cefuroxime 1500 mg
A high-potency, second-generation cephalosporin antibiotic injection formulated for the intensive treatment of serious respiratory and systemic infections. Axicef 1500 MG contains Cefuroxime Sodium, a broad-spectrum antimicrobial agent designed to provide rapid bactericidal action and a high degree of stability against bacterial enzymes.
A high-potency, second-generation cephalosporin antibiotic injection formulated for the intensive treatment of serious respiratory and systemic infections. Axicef 1500 MG contains Cefuroxime Sodium, a broad-spectrum antimicrobial agent designed to provide rapid bactericidal action and a high degree of stability against bacterial enzymes.
Cefuroxime 1500mg works by inhibiting the synthesis of the bacterial cell wall. By binding to specific penicillin-binding proteins (PBPs), it prevents the cross-linking of peptidoglycan chains, leading to the structural collapse and death of the bacteria.
The molecular structure of Cefuroxime provides significant resistance to many beta-lactamase enzymes produced by bacteria. This ensures that the medication remains potent against many strains that have developed resistance to earlier penicillins and first-generation cephalosporins.
Axicef 1500 MG offers a balanced antimicrobial spectrum, showing high efficacy against Gram-positive cocci (including Staphylococcus and Streptococcus) and an expanded range of Gram-negative organisms like E. coli and Klebsiella.
The formulation demonstrates excellent distribution into the lungs and bronchial secretions. This makes it a gold-standard choice for treating severe community-acquired pneumonia and acute exacerbations of chronic bronchitis.
Administered intravenously before surgery, this high-dose injection provides a protective barrier against post-operative site infections. It is particularly effective in orthopedic, pelvic, and cardiovascular surgeries where skin-borne pathogens are a risk.
The injectable delivery ensures 100% absorption and immediate therapeutic plasma levels. This rapid onset is essential for managing acute infections in hospitalized patients who require fast-acting clinical intervention.
Indication Lower Respiratory Tract Infections (Pneumonia), Complicated Urinary Tract Infections, Skin and Soft Tissue Infections, Bone and Joint Infections, Septicemia, Pre- and Post-Operative Surgical Prophylaxis.
Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.
